↓ Skip to main content

CAPE-pNO2 Inhibited the Growth and Metastasis of Triple-Negative Breast Cancer via the EGFR/STAT3/Akt/E-Cadherin Signaling Pathway

Overview of attention for article published in Frontiers in oncology, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CAPE-pNO2 Inhibited the Growth and Metastasis of Triple-Negative Breast Cancer via the EGFR/STAT3/Akt/E-Cadherin Signaling Pathway
Published in
Frontiers in oncology, June 2019
DOI 10.3389/fonc.2019.00461
Pubmed ID
Authors

Qin Huang, Sai Li, Liwen Zhang, Xufang Qiao, Yanyan Zhang, Xiaoyan Zhao, Guojun Xiao, Zhubo Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 19%
Student > Master 3 14%
Researcher 3 14%
Student > Ph. D. Student 2 10%
Other 2 10%
Other 3 14%
Unknown 4 19%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 5 24%
Biochemistry, Genetics and Molecular Biology 5 24%
Medicine and Dentistry 3 14%
Chemistry 2 10%
Agricultural and Biological Sciences 1 5%
Other 1 5%
Unknown 4 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 December 2021.
All research outputs
#20,246,480
of 25,746,891 outputs
Outputs from Frontiers in oncology
#9,484
of 22,775 outputs
Outputs of similar age
#265,370
of 367,871 outputs
Outputs of similar age from Frontiers in oncology
#161
of 289 outputs
Altmetric has tracked 25,746,891 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,775 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,871 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 289 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.